The Faber Difference
Values & Community
Our Clients
Areas of Expertise
Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity - while our licensing professionals have drafted and negotiated countless agreements securing intellectual rights to foundational technologies
Getting ready for a global Phase 2 or 3 clinical trial
Our experienced contracts specialists work alongside attorneys steeped in the business side of life sciences
Establishing a pharmaceutical supply chain
Our team of professionals understands the industry-specific drivers of complex supply chains
The Faber Difference
Values & Community
Our Clients
Areas of Expertise
Launching a drug development company with novel technology from academia
Our corporate group has worked with hundreds of entrepreneurs at this stage to help them optimally and efficiently select and form the appropriate legal entity - while our licensing professionals have drafted and negotiated countless agreements securing intellectual rights to foundational technologies
Getting ready for a global Phase 2 or 3 clinical trial
Our experienced contracts specialists work alongside attorneys steeped in the business side of life sciences
Establishing a pharmaceutical supply chain
Our team of professionals understands the industry-specific drivers of complex supply chains
News
Faber Daeufer & Itrato proudly announces the promotion of Lily Vakili to Principal. Vakili advises clients in the practice areas of Industry Collaborations, Licensing and Supply Chain Documentation. Recent transactions include representation of a large investor syndicate in the negotiation of a clinical development and manufacturing agreement for an exclusively in-licensed respiratory disease drug product and advising a Boston-based subsidiary of a large international biopharmaceutical company in CMC-related documentation for the development of a pipeline of cancer immunotherapies.
Vakili co-presented the firm’s 2020 client webinar on Manufacturing Agreements and participated as a Speaker at ACI’s Women Leaders in Life Sciences Law 2020 Conference.
In addition to her work with clients, Vakili currently serves as Chair of the firm’s Equity, Diversity and Inclusion Committee (EDIC).
Faber is a dynamic, independent law firm that provides corporate and transactional counsel to clients in the life sciences industry and in other emerging technology sectors. Since its founding in 2003, the firm has built a premier boutique practice working with over 1,000 companies, research institutions and investors. The firm includes 24 lawyers, 8 contracts specialists, 1 corporate paralegal and 9 technology, finance and administration professionals. The firm is based in Waltham, Massachusetts and has offices in Oakland, New York and Philadelphia.